Methods to Predict and Lower the Risk of Prostate Cancer
Chemoprevention for prostate cancer (PCa) continues to generate interest from both physicians and the patient population. The goal of chemoprevention is to stop the malignant transformation of prostate cells into cancer. Multiple studies on different substances ranging from supplements to medical th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2011.72 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849413015699456000 |
|---|---|
| author | Barbara Ercole Dipen J. Parekh |
| author_facet | Barbara Ercole Dipen J. Parekh |
| author_sort | Barbara Ercole |
| collection | DOAJ |
| description | Chemoprevention for prostate cancer (PCa) continues to generate interest from both physicians and the patient population. The goal of chemoprevention is to stop the malignant transformation of prostate cells into cancer. Multiple studies on different substances ranging from supplements to medical therapy have been undertaken. Thus far, only the studies on 5α-reductase inhibitors (the Prostate Cancer Prevention Trial [PCPT] and Reduction by Dutasteride of Prostate Cancer Events [REDUCE] trial) have demonstrated a reduction in the risk of PCa, while results from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) concluded no decreased risk for PCa with selenium or vitamin E. |
| format | Article |
| id | doaj-art-49f9d612c85645e2b9588a6c3fbb2ff4 |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-49f9d612c85645e2b9588a6c3fbb2ff42025-08-20T03:34:17ZengWileyThe Scientific World Journal1537-744X2011-01-011174274810.1100/tsw.2011.72Methods to Predict and Lower the Risk of Prostate CancerBarbara Ercole0Dipen J. Parekh1Department of Urology, University of Texas Health Science Center, San Antonio, USADepartment of Urology, University of Texas Health Science Center, San Antonio, USAChemoprevention for prostate cancer (PCa) continues to generate interest from both physicians and the patient population. The goal of chemoprevention is to stop the malignant transformation of prostate cells into cancer. Multiple studies on different substances ranging from supplements to medical therapy have been undertaken. Thus far, only the studies on 5α-reductase inhibitors (the Prostate Cancer Prevention Trial [PCPT] and Reduction by Dutasteride of Prostate Cancer Events [REDUCE] trial) have demonstrated a reduction in the risk of PCa, while results from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) concluded no decreased risk for PCa with selenium or vitamin E.http://dx.doi.org/10.1100/tsw.2011.72 |
| spellingShingle | Barbara Ercole Dipen J. Parekh Methods to Predict and Lower the Risk of Prostate Cancer The Scientific World Journal |
| title | Methods to Predict and Lower the Risk of Prostate Cancer |
| title_full | Methods to Predict and Lower the Risk of Prostate Cancer |
| title_fullStr | Methods to Predict and Lower the Risk of Prostate Cancer |
| title_full_unstemmed | Methods to Predict and Lower the Risk of Prostate Cancer |
| title_short | Methods to Predict and Lower the Risk of Prostate Cancer |
| title_sort | methods to predict and lower the risk of prostate cancer |
| url | http://dx.doi.org/10.1100/tsw.2011.72 |
| work_keys_str_mv | AT barbaraercole methodstopredictandlowertheriskofprostatecancer AT dipenjparekh methodstopredictandlowertheriskofprostatecancer |